OGEN vs T · rev $37.7K vs P/E 7.4, rev $125.65B
Oragenics Inc (OGEN) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
OGEN currently screens at market cap $2.7M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the OGEN and T stock pages for the full models.
Not investment advice.